Table 1.
Baseline characteristics
| Total N = 68 | Microadenomas N = 8 | Macroadenomas N = 60 | P* | |
|---|---|---|---|---|
| Age (years) | ||||
| Mean ± SD | 49·7 ± 13·2 | 60 ± 9·3 | 48·3 ± 13·1 | |
| Median | 50 | 57·5 | 47·5 | 0·02 |
| Range | 24–77 | 49–77 | 24–71 | |
| Male/female | 28/40 | 4/4 | 24/36 | 0·7 |
| mGH (µg/l) | ||||
| Mean ± SD | 33·6 ± 62·6 | 5·5 ± 2·6 | 37·4 ± 65·8 | |
| Median | 9·5 | 5·3 | 13·1 | 0·008 |
| Range | 2–391 | 2·3–9·1 | 2–391 | |
| IGF-1(µg/l) | ||||
| Mean ± SD | 676 ± 275 | 570 ± 124 | 690 ± 287 | |
| Median | 616 | 565 | 617 | 0·19 |
| Range | 277–1974 | 391–720 | 277–1974 | |
| Tumour volume (mm3) | ||||
| Mean ± SD | 3463 ± 4905 | 298 ± 145 | 3885 ± 5077 | |
| Median | 1210 | 308 | 1608 | < 0·0001 |
| Range | 59–22 702 | 86–528 | 59–22 702 | |
*
Wilcoxon test for continuous variables, Fisher's exact test for gender.